Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Europe Alpha-glucosidase Inhibitors Market Report 2021

  • QYR658226
  • 102 Pages
  • August 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
This report studies sales (consumption) of Alpha-glucosidase Inhibitors in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

Sanofi

Bayer

Takeda Pharmaceuticals

Eli Lilly

Merck & Co.

Novo Nordisk

Bristol-Myers Squibb

Pfizer

AstraZeneca

GlaxoSmithKline

Boehringer Ingelheim

...

Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of Alpha-glucosidase Inhibitors in these regions, from 2011 to 2021 (forecast), like

Germany

France

UK

Italy

Spain

Russia

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type 1

Type 2

Type 3

Split by applications, this report focuses on sales, market share and growth rate of Alpha-glucosidase Inhibitors in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

1 Alpha-glucosidase Inhibitors Overview

1.1 Product Overview and Scope of Alpha-glucosidase Inhibitors

1.2 Classification of Alpha-glucosidase Inhibitors

1.3 Applications of Alpha-glucosidase Inhibitors

1.4 Alpha-glucosidase Inhibitors Market by Regions

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Italy Status and Prospect (2011-2021)

1.4.5 Spain Status and Prospect (2011-2021)

1.4.6 Russia Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Alpha-glucosidase Inhibitors (2011-2021)

1.5.1 Europe Alpha-glucosidase Inhibitors Sales, Revenue and Price (2011-2021)

1.5.2 Europe Alpha-glucosidase Inhibitors Sales and Growth Rate (2011-2021)

1.5.3 Europe Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

2 Europe Alpha-glucosidase Inhibitors by Manufacturers, Type and Application

2.1 Europe Alpha-glucosidase Inhibitors Market Competition by Manufacturers

2.1.1 Europe Alpha-glucosidase Inhibitors Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Alpha-glucosidase Inhibitors Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Alpha-glucosidase Inhibitors (Volume and Value) by Type

2.2.1 Europe Alpha-glucosidase Inhibitors Sales and Market Share by Type (2011-2021)

2.2.2 Europe Alpha-glucosidase Inhibitors Revenue and Market Share by Type (2011-2021)

2.3 Europe Alpha-glucosidase Inhibitors (Volume and Value) by Regions

2.3.1 Europe Alpha-glucosidase Inhibitors Sales and Market Share by Regions (2011-2021)

2.3.2 Europe Alpha-glucosidase Inhibitors Revenue and Market Share by Regions (2011-2021)

2.4 Europe Alpha-glucosidase Inhibitors (Volume) by Application

3 Germany Alpha-glucosidase Inhibitors (Volume, Value and Sales Price)

3.1 Germany Alpha-glucosidase Inhibitors Sales and Value (2011-2021)

3.1.1 Germany Alpha-glucosidase Inhibitors Sales and Growth Rate (2011-2021)

3.1.2 Germany Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

3.1.3 Germany Alpha-glucosidase Inhibitors Sales Price Trend (2011-2021)

3.2 Germany Alpha-glucosidase Inhibitors Sales and Market Share by Manufacturers

3.3 Germany Alpha-glucosidase Inhibitors Sales and Market Share by Type

3.4 Germany Alpha-glucosidase Inhibitors Sales and Market Share by Applications

4 UK Alpha-glucosidase Inhibitors (Volume, Value and Sales Price)

4.1 UK Alpha-glucosidase Inhibitors Sales and Value (2011-2021)

4.1.1 UK Alpha-glucosidase Inhibitors Sales and Growth Rate (2011-2021)

4.1.2 UK Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

4.1.3 UK Alpha-glucosidase Inhibitors Sales Price Trend (2011-2021)

4.2 UK Alpha-glucosidase Inhibitors Sales and Market Share by Manufacturers

4.3 UK Alpha-glucosidase Inhibitors Sales and Market Share by Type

4.4 UK Alpha-glucosidase Inhibitors Sales and Market Share by Applications

5 France Alpha-glucosidase Inhibitors (Volume, Value and Sales Price)

5.1 France Alpha-glucosidase Inhibitors Sales and Value (2011-2021)

5.1.1 France Alpha-glucosidase Inhibitors Sales and Growth Rate (2011-2021)

5.1.2 France Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

5.1.3 France Alpha-glucosidase Inhibitors Sales Price Trend (2011-2021)

5.2 France Alpha-glucosidase Inhibitors Sales and Market Share by Manufacturers

5.3 France Alpha-glucosidase Inhibitors Sales and Market Share by Type

5.4 France Alpha-glucosidase Inhibitors Sales and Market Share by Applications

6 Italy Alpha-glucosidase Inhibitors (Volume, Value and Sales Price)

6.1 Italy Alpha-glucosidase Inhibitors Sales and Value (2011-2021)

6.1.1 Italy Alpha-glucosidase Inhibitors Sales and Growth Rate (2011-2021)

6.1.2 Italy Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

6.1.3 Italy Alpha-glucosidase Inhibitors Sales Price Trend (2011-2021)

6.2 Italy Alpha-glucosidase Inhibitors Sales and Market Share by Manufacturers

6.3 Italy Alpha-glucosidase Inhibitors Sales and Market Share by Type

6.4 Italy Alpha-glucosidase Inhibitors Sales and Market Share by Applications

7 Russia Alpha-glucosidase Inhibitors (Volume, Value and Sales Price)

7.1 Russia Alpha-glucosidase Inhibitors Sales and Value (2011-2021)

7.1.1 Russia Alpha-glucosidase Inhibitors Sales and Growth Rate (2011-2021)

7.1.2 Russia Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

7.1.3 Russia Alpha-glucosidase Inhibitors Sales Price Trend (2011-2021)

7.2 Russia Alpha-glucosidase Inhibitors Sales and Market Share by Manufacturers

7.3 Russia Alpha-glucosidase Inhibitors Sales and Market Share by Type

7.4 Russia Alpha-glucosidase Inhibitors Sales and Market Share by Applications

8 Spain Alpha-glucosidase Inhibitors (Volume, Value and Sales Price)

8.1 Spain Alpha-glucosidase Inhibitors Sales and Value (2011-2021)

8.1.1 Spain Alpha-glucosidase Inhibitors Sales and Growth Rate (2011-2021)

8.1.2 Spain Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

8.1.3 Spain Alpha-glucosidase Inhibitors Sales Price Trend (2011-2021)

8.2 Spain Alpha-glucosidase Inhibitors Sales and Market Share by Manufacturers

8.3 Spain Alpha-glucosidase Inhibitors Sales and Market Share by Type

8.4 Spain Alpha-glucosidase Inhibitors Sales and Market Share by Applications

9 Europe Alpha-glucosidase Inhibitors Manufacturers Analysis

9.1 Sanofi

9.1.1 Company Basic Information,Manufacturing Base and Competitors

9.1.2 Alpha-glucosidase Inhibitors Product Type and Technology

9.1.2.1 Type 1

9.1.2.2 Type 2

9.1.3 Alpha-glucosidase Inhibitors Sales, Revenue, Price of Sanofi (2015 and 2016)

9.2 Bayer

9.2.1 Company Basic Information,Manufacturing Base and Competitors

9.2.2 Alpha-glucosidase Inhibitors Product Type and Technology

9.2.2.1 Type 1

9.2.2.2 Type 2

9.2.3 Alpha-glucosidase Inhibitors Sales, Revenue, Price of Bayer (2015 and 2016)

9.3 Takeda Pharmaceuticals

9.3.1 Company Basic Information,Manufacturing Base and Competitors

9.3.2 Alpha-glucosidase Inhibitors Product Type and Technology

9.3.2.1 Type 1

9.3.2.2 Type 2

9.3.3 Alpha-glucosidase Inhibitors Sales, Revenue, Price of Takeda Pharmaceuticals (2015 and 2016)

9.4 Eli Lilly

9.4.1 Company Basic Information,Manufacturing Base and Competitors

9.4.2 Alpha-glucosidase Inhibitors Product Type and Technology

9.4.2.1 Type 1

9.4.2.2 Type 2

9.4.3 Alpha-glucosidase Inhibitors Sales, Revenue, Price of Eli Lilly (2015 and 2016)

9.5 Merck & Co.

9.5.1 Company Basic Information,Manufacturing Base and Competitors

9.5.2 Alpha-glucosidase Inhibitors Product Type and Technology

9.5.2.1 Type 1

9.5.2.2 Type 2

9.5.3 Alpha-glucosidase Inhibitors Sales, Revenue, Price of Merck & Co. (2015 and 2016)

9.6 Novo Nordisk

9.6.1 Company Basic Information,Manufacturing Base and Competitors

9.6.2 Alpha-glucosidase Inhibitors Product Type and Technology

9.6.2.1 Type 1

9.6.2.2 Type 2

9.6.3 Alpha-glucosidase Inhibitors Sales, Revenue, Price of Novo Nordisk (2015 and 2016)

9.7 Bristol-Myers Squibb

9.7.1 Company Basic Information,Manufacturing Base and Competitors

9.7.2 Alpha-glucosidase Inhibitors Product Type and Technology

9.7.2.1 Type 1

9.7.2.2 Type 2

9.7.3 Alpha-glucosidase Inhibitors Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)

9.8 Pfizer

9.8.1 Company Basic Information,Manufacturing Base and Competitors

9.8.2 Alpha-glucosidase Inhibitors Product Type and Technology

9.8.2.1 Type 1

9.8.2.2 Type 2

9.8.3 Alpha-glucosidase Inhibitors Sales, Revenue, Price of Pfizer (2015 and 2016)

9.9 AstraZeneca

9.9.1 Company Basic Information,Manufacturing Base and Competitors

9.9.2 Alpha-glucosidase Inhibitors Product Type and Technology

9.9.2.1 Type 1

9.9.2.2 Type 2

9.9.3 Alpha-glucosidase Inhibitors Sales, Revenue, Price of AstraZeneca (2015 and 2016)

9.10 GlaxoSmithKline

9.10.1 Company Basic Information,Manufacturing Base and Competitors

9.10.2 Alpha-glucosidase Inhibitors Product Type and Technology

9.10.2.1 Type 1

9.10.2.2 Type 2

9.10.3 Alpha-glucosidase Inhibitors Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)

9.11 Boehringer Ingelheim

9.11.1 Company Basic Information,Manufacturing Base and Competitors

9.11.2 Alpha-glucosidase Inhibitors Product Type and Technology

9.11.2.1 Type 1

9.11.2.2 Type 2

9.11.3 Alpha-glucosidase Inhibitors Sales, Revenue, Price of Boehringer Ingelheim (2015 and 2016)

10 Alpha-glucosidase Inhibitors Technology and Development Trend

10.1 Alpha-glucosidase Inhibitors Technology Analysis

10.2 Alpha-glucosidase Inhibitors Technology Development Trend

11 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Alpha-glucosidase Inhibitors

Table Classification of Alpha-glucosidase Inhibitors

Figure Europe Sales Market Share of Alpha-glucosidase Inhibitors by Types in 2015

Table Applications of Alpha-glucosidase Inhibitors

Figure Europe Sales Market Share of Alpha-glucosidase Inhibitors by Applications in 2015

Figure Germany Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

Figure France Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

Figure UK Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

Figure Italy Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

Figure Spain Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

Figure Russia Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

Table Europe Alpha-glucosidase Inhibitors Sales, Revenue and Price (2011-2021)

Figure Europe Alpha-glucosidase Inhibitors Sales and Growth Rate (2011-2021)

Figure Europe Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

Table Europe Alpha-glucosidase Inhibitors Sales of Key Manufacturers (2015 and 2016)

Table Europe Alpha-glucosidase Inhibitors Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Alpha-glucosidase Inhibitors Sales Share by Manufacturers

Figure 2016 Alpha-glucosidase Inhibitors Sales Share by Manufacturers

Table Europe Alpha-glucosidase Inhibitors Revenue by Manufacturers (2015 and 2016)

Table Europe Alpha-glucosidase Inhibitors Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Alpha-glucosidase Inhibitors Revenue Share by Manufacturers

Table 2016 Europe Alpha-glucosidase Inhibitors Revenue Share by Manufacturers

Table Europe Alpha-glucosidase Inhibitors Sales and Market Share by Type (2011-2021)

Table Europe Alpha-glucosidase Inhibitors Sales Share by Type (2011-2021)

Figure Sales Market Share of Alpha-glucosidase Inhibitors by Type (2011-2021)

Figure Europe Alpha-glucosidase Inhibitors Sales Growth Rate by Type (2011-2021)

Table Europe Alpha-glucosidase Inhibitors Revenue and Market Share by Type (2011-2021)

Table Europe Alpha-glucosidase Inhibitors Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Alpha-glucosidase Inhibitors by Type (2011-2021)

Figure Europe Alpha-glucosidase Inhibitors Revenue Growth Rate by Type (2011-2021)

Table Europe Alpha-glucosidase Inhibitors Sales and Market Share by Regions (2011-2021)

Table Europe Alpha-glucosidase Inhibitors Sales Share by Regions (2011-2021)

Figure Sales Market Share of Alpha-glucosidase Inhibitors by Regions (2011-2021)

Figure Europe Alpha-glucosidase Inhibitors Sales Growth Rate by Regions (2011-2021)

Table Europe Alpha-glucosidase Inhibitors Revenue and Market Share by Regions (2011-2021)

Table Europe Alpha-glucosidase Inhibitors Revenue Share by Regions (2011-2021)

Figure Revenue Market Share of Alpha-glucosidase Inhibitors by Regions (2011-2021)

Figure Europe Alpha-glucosidase Inhibitors Revenue Growth Rate by Regions (2011-2021)

Table Europe Alpha-glucosidase Inhibitors Sales and Market Share by Application (2011-2021)

Table Europe Alpha-glucosidase Inhibitors Sales Share by Application (2011-2021)

Figure Sales Market Share of Alpha-glucosidase Inhibitors by Application (2011-2021)

Figure Europe Alpha-glucosidase Inhibitors Sales Growth Rate by Application (2011-2021)

Figure Germany Alpha-glucosidase Inhibitors Sales and Growth Rate (2011-2021)

Figure Germany Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

Figure Germany Alpha-glucosidase Inhibitors Sales Price Trend (2011-2021)

Table Germany Alpha-glucosidase Inhibitors Sales by Manufacturers (2015 and 2016)

Table Germany Alpha-glucosidase Inhibitors Market Share by Manufacturers (2015 and 2016)

Table Germany Alpha-glucosidase Inhibitors Sales by Type (2015 and 2016)

Table Germany Alpha-glucosidase Inhibitors Market Share by Type (2015 and 2016)

Table Germany Alpha-glucosidase Inhibitors Sales by Applications (2015 and 2016)

Table Germany Alpha-glucosidase Inhibitors Market Share by Applications (2015 and 2016)

Figure UK Alpha-glucosidase Inhibitors Sales and Growth Rate (2011-2021)

Figure UK Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

Figure UK Alpha-glucosidase Inhibitors Sales Price Trend (2011-2021)

Table UK Alpha-glucosidase Inhibitors Sales by Manufacturers (2015 and 2016)

Table UK Alpha-glucosidase Inhibitors Market Share by Manufacturers (2015 and 2016)

Table UK Alpha-glucosidase Inhibitors Sales by Type (2015 and 2016)

Table UK Alpha-glucosidase Inhibitors Market Share by Type (2015 and 2016)

Table UK Alpha-glucosidase Inhibitors Sales by Applications (2015 and 2016)

Table UK Alpha-glucosidase Inhibitors Market Share by Applications (2015 and 2016)

Figure France Alpha-glucosidase Inhibitors Sales and Growth Rate (2011-2021)

Figure France Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

Figure France Alpha-glucosidase Inhibitors Sales Price Trend (2011-2021)

Table France Alpha-glucosidase Inhibitors Sales by Manufacturers (2015 and 2016)

Table France Alpha-glucosidase Inhibitors Market Share by Manufacturers (2015 and 2016)

Table France Alpha-glucosidase Inhibitors Sales by Type (2015 and 2016)

Table France Alpha-glucosidase Inhibitors Market Share by Type (2015 and 2016)

Table France Alpha-glucosidase Inhibitors Sales by Applications (2015 and 2016)

Table France Alpha-glucosidase Inhibitors Market Share by Applications (2015 and 2016)

Figure Italy Alpha-glucosidase Inhibitors Sales and Growth Rate (2011-2021)

Figure Italy Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

Figure Italy Alpha-glucosidase Inhibitors Sales Price Trend (2011-2021)

Table Italy Alpha-glucosidase Inhibitors Sales by Manufacturers (2015 and 2016)

Table Italy Alpha-glucosidase Inhibitors Market Share by Manufacturers (2015 and 2016)

Table Italy Alpha-glucosidase Inhibitors Sales by Type (2015 and 2016)

Table Italy Alpha-glucosidase Inhibitors Market Share by Type (2015 and 2016)

Table Italy Alpha-glucosidase Inhibitors Sales by Applications (2015 and 2016)

Table Italy Alpha-glucosidase Inhibitors Market Share by Applications (2015 and 2016)

Figure Russia Alpha-glucosidase Inhibitors Sales and Growth Rate (2011-2021)

Figure Russia Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

Figure Russia Alpha-glucosidase Inhibitors Sales Price Trend (2011-2021)

Table Russia Alpha-glucosidase Inhibitors Sales by Manufacturers (2015 and 2016)

Table Russia Alpha-glucosidase Inhibitors Market Share by Manufacturers (2015 and 2016)

Table Russia Alpha-glucosidase Inhibitors Sales by Type (2015 and 2016)

Table Russia Alpha-glucosidase Inhibitors Market Share by Type (2015 and 2016)

Table Russia Alpha-glucosidase Inhibitors Sales by Applications (2015 and 2016)

Table Russia Alpha-glucosidase Inhibitors Market Share by Applications (2015 and 2016)

Figure Spain Alpha-glucosidase Inhibitors Sales and Growth Rate (2011-2021)

Figure Spain Alpha-glucosidase Inhibitors Revenue and Growth Rate (2011-2021)

Figure Spain Alpha-glucosidase Inhibitors Sales Price Trend (2011-2021)

Table Spain Alpha-glucosidase Inhibitors Sales by Manufacturers (2015 and 2016)

Table Spain Alpha-glucosidase Inhibitors Market Share by Manufacturers (2015 and 2016)

Table Spain Alpha-glucosidase Inhibitors Sales by Type (2015 and 2016)

Table Spain Alpha-glucosidase Inhibitors Market Share by Type (2015 and 2016)

Table Spain Alpha-glucosidase Inhibitors Sales by Applications (2015 and 2016)

Table Spain Alpha-glucosidase Inhibitors Market Share by Applications (2015 and 2016)

Table Sanofi Basic Information List

Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of Sanofi (2015 and 2016)

Table Bayer Basic Information List

Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of Bayer (2015 and 2016)

Table Takeda Pharmaceuticals Basic Information List

Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of Takeda Pharmaceuticals (2015 and 2016)

Table Eli Lilly Basic Information List

Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of Eli Lilly (2015 and 2016)

Table Merck & Co. Basic Information List

Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of Merck & Co. (2015 and 2016)

Table Novo Nordisk Basic Information List

Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of Novo Nordisk (2015 and 2016)

Table Bristol-Myers Squibb Basic Information List

Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)

Table Pfizer Basic Information List

Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of Pfizer (2015 and 2016)

Table AstraZeneca Basic Information List

Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of AstraZeneca (2015 and 2016)

Table GlaxoSmithKline Basic Information List

Table Alpha-glucosidase Inhibitors Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)

...

Table Novo Nordisk Basic Information List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390